Diabetic Retinopathy Treatment Market, Global Outlook and Forecast 2022-2028

March 2022 | 107 pages | ID: D0A65D8C79E7EN
Market Monitor Global

Abstracts

Diabetic retinopathy (die-uh-BET-ik ret-ih-NOP-uh-thee) is a diabetes complication that affects eyes. It's caused by damage to the blood vessels of the light-sensitive tissue at the back of the eye (retina).

This report contains market size and forecasts of Diabetic Retinopathy Treatment in Global, including the following market information:

Global Diabetic Retinopathy Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Diabetic Retinopathy Treatment market was valued at 7394.3 million in 2021 and is projected to reach US$ 9907.5 million by 2028, at a CAGR of 4.3% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Proliferative Diabetic Retinopathy (PDR) Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Diabetic Retinopathy Treatment include Regeneron Pharmaceuticals, ThromboGenics, Genentech, Bayer Healthcare, Alimera Sciences, Actavis, BCN Peptides, Novartis and Ampio Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Diabetic Retinopathy Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Diabetic Retinopathy Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Diabetic Retinopathy Treatment Market Segment Percentages, by Type, 2021 (%)

• Proliferative Diabetic Retinopathy (PDR)
• Non-Proliferative Diabetic Retinopathy (NPDR)

Global Diabetic Retinopathy Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Diabetic Retinopathy Treatment Market Segment Percentages, by Application, 2021 (%)

• Ophthalmic Clinics
• Ambulatory Surgical Centers
• Hospitals
• Other

Global Diabetic Retinopathy Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Diabetic Retinopathy Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Diabetic Retinopathy Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Diabetic Retinopathy Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Regeneron Pharmaceuticals
• ThromboGenics
• Genentech
• Bayer Healthcare
• Alimera Sciences
• Actavis
• BCN Peptides
• Novartis
• Ampio Pharmaceuticals
• Kowa Group
• Sirnaomicsorporation
• Abbott Laboratories
• Glycadia Pharmaceuticals
• Alcon Laboratories
• Parexel International

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Diabetic Retinopathy Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Diabetic Retinopathy Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL DIABETIC RETINOPATHY TREATMENT OVERALL MARKET SIZE

2.1 Global Diabetic Retinopathy Treatment Market Size: 2021 VS 2028
2.2 Global Diabetic Retinopathy Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Diabetic Retinopathy Treatment Players in Global Market
3.2 Top Global Diabetic Retinopathy Treatment Companies Ranked by Revenue
3.3 Global Diabetic Retinopathy Treatment Revenue by Companies
3.4 Top 3 and Top 5 Diabetic Retinopathy Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Diabetic Retinopathy Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Diabetic Retinopathy Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Diabetic Retinopathy Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Diabetic Retinopathy Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Diabetic Retinopathy Treatment Market Size Markets, 2021 & 2028
  4.1.2 Proliferative Diabetic Retinopathy (PDR)
  4.1.3 Non-Proliferative Diabetic Retinopathy (NPDR)
4.2 By Type - Global Diabetic Retinopathy Treatment Revenue & Forecasts
  4.2.1 By Type - Global Diabetic Retinopathy Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Diabetic Retinopathy Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Diabetic Retinopathy Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Diabetic Retinopathy Treatment Market Size, 2021 & 2028
  5.1.2 Ophthalmic Clinics
  5.1.3 Ambulatory Surgical Centers
  5.1.4 Hospitals
  5.1.5 Other
5.2 By Application - Global Diabetic Retinopathy Treatment Revenue & Forecasts
  5.2.1 By Application - Global Diabetic Retinopathy Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Diabetic Retinopathy Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Diabetic Retinopathy Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Diabetic Retinopathy Treatment Market Size, 2021 & 2028
6.2 By Region - Global Diabetic Retinopathy Treatment Revenue & Forecasts
  6.2.1 By Region - Global Diabetic Retinopathy Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Diabetic Retinopathy Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Diabetic Retinopathy Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Diabetic Retinopathy Treatment Revenue, 2017-2028
  6.3.2 US Diabetic Retinopathy Treatment Market Size, 2017-2028
  6.3.3 Canada Diabetic Retinopathy Treatment Market Size, 2017-2028
  6.3.4 Mexico Diabetic Retinopathy Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Diabetic Retinopathy Treatment Revenue, 2017-2028
  6.4.2 Germany Diabetic Retinopathy Treatment Market Size, 2017-2028
  6.4.3 France Diabetic Retinopathy Treatment Market Size, 2017-2028
  6.4.4 U.K. Diabetic Retinopathy Treatment Market Size, 2017-2028
  6.4.5 Italy Diabetic Retinopathy Treatment Market Size, 2017-2028
  6.4.6 Russia Diabetic Retinopathy Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Diabetic Retinopathy Treatment Market Size, 2017-2028
  6.4.8 Benelux Diabetic Retinopathy Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Diabetic Retinopathy Treatment Revenue, 2017-2028
  6.5.2 China Diabetic Retinopathy Treatment Market Size, 2017-2028
  6.5.3 Japan Diabetic Retinopathy Treatment Market Size, 2017-2028
  6.5.4 South Korea Diabetic Retinopathy Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Diabetic Retinopathy Treatment Market Size, 2017-2028
  6.5.6 India Diabetic Retinopathy Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Diabetic Retinopathy Treatment Revenue, 2017-2028
  6.6.2 Brazil Diabetic Retinopathy Treatment Market Size, 2017-2028
  6.6.3 Argentina Diabetic Retinopathy Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Diabetic Retinopathy Treatment Revenue, 2017-2028
  6.7.2 Turkey Diabetic Retinopathy Treatment Market Size, 2017-2028
  6.7.3 Israel Diabetic Retinopathy Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Diabetic Retinopathy Treatment Market Size, 2017-2028
  6.7.5 UAE Diabetic Retinopathy Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Regeneron Pharmaceuticals
  7.1.1 Regeneron Pharmaceuticals Corporate Summary
  7.1.2 Regeneron Pharmaceuticals Business Overview
  7.1.3 Regeneron Pharmaceuticals Diabetic Retinopathy Treatment Major Product Offerings
  7.1.4 Regeneron Pharmaceuticals Diabetic Retinopathy Treatment Revenue in Global Market (2017-2022)
  7.1.5 Regeneron Pharmaceuticals Key News
7.2 ThromboGenics
  7.2.1 ThromboGenics Corporate Summary
  7.2.2 ThromboGenics Business Overview
  7.2.3 ThromboGenics Diabetic Retinopathy Treatment Major Product Offerings
  7.2.4 ThromboGenics Diabetic Retinopathy Treatment Revenue in Global Market (2017-2022)
  7.2.5 ThromboGenics Key News
7.3 Genentech
  7.3.1 Genentech Corporate Summary
  7.3.2 Genentech Business Overview
  7.3.3 Genentech Diabetic Retinopathy Treatment Major Product Offerings
  7.3.4 Genentech Diabetic Retinopathy Treatment Revenue in Global Market (2017-2022)
  7.3.5 Genentech Key News
7.4 Bayer Healthcare
  7.4.1 Bayer Healthcare Corporate Summary
  7.4.2 Bayer Healthcare Business Overview
  7.4.3 Bayer Healthcare Diabetic Retinopathy Treatment Major Product Offerings
  7.4.4 Bayer Healthcare Diabetic Retinopathy Treatment Revenue in Global Market (2017-2022)
  7.4.5 Bayer Healthcare Key News
7.5 Alimera Sciences
  7.5.1 Alimera Sciences Corporate Summary
  7.5.2 Alimera Sciences Business Overview
  7.5.3 Alimera Sciences Diabetic Retinopathy Treatment Major Product Offerings
  7.5.4 Alimera Sciences Diabetic Retinopathy Treatment Revenue in Global Market (2017-2022)
  7.5.5 Alimera Sciences Key News
7.6 Actavis
  7.6.1 Actavis Corporate Summary
  7.6.2 Actavis Business Overview
  7.6.3 Actavis Diabetic Retinopathy Treatment Major Product Offerings
  7.6.4 Actavis Diabetic Retinopathy Treatment Revenue in Global Market (2017-2022)
  7.6.5 Actavis Key News
7.7 BCN Peptides
  7.7.1 BCN Peptides Corporate Summary
  7.7.2 BCN Peptides Business Overview
  7.7.3 BCN Peptides Diabetic Retinopathy Treatment Major Product Offerings
  7.7.4 BCN Peptides Diabetic Retinopathy Treatment Revenue in Global Market (2017-2022)
  7.7.5 BCN Peptides Key News
7.8 Novartis
  7.8.1 Novartis Corporate Summary
  7.8.2 Novartis Business Overview
  7.8.3 Novartis Diabetic Retinopathy Treatment Major Product Offerings
  7.8.4 Novartis Diabetic Retinopathy Treatment Revenue in Global Market (2017-2022)
  7.8.5 Novartis Key News
7.9 Ampio Pharmaceuticals
  7.9.1 Ampio Pharmaceuticals Corporate Summary
  7.9.2 Ampio Pharmaceuticals Business Overview
  7.9.3 Ampio Pharmaceuticals Diabetic Retinopathy Treatment Major Product Offerings
  7.9.4 Ampio Pharmaceuticals Diabetic Retinopathy Treatment Revenue in Global Market (2017-2022)
  7.9.5 Ampio Pharmaceuticals Key News
7.10 Kowa Group
  7.10.1 Kowa Group Corporate Summary
  7.10.2 Kowa Group Business Overview
  7.10.3 Kowa Group Diabetic Retinopathy Treatment Major Product Offerings
  7.10.4 Kowa Group Diabetic Retinopathy Treatment Revenue in Global Market (2017-2022)
  7.10.5 Kowa Group Key News
7.11 Sirnaomicsorporation
  7.11.1 Sirnaomicsorporation Corporate Summary
  7.11.2 Sirnaomicsorporation Business Overview
  7.11.3 Sirnaomicsorporation Diabetic Retinopathy Treatment Major Product Offerings
  7.11.4 Sirnaomicsorporation Diabetic Retinopathy Treatment Revenue in Global Market (2017-2022)
  7.11.5 Sirnaomicsorporation Key News
7.12 Abbott Laboratories
  7.12.1 Abbott Laboratories Corporate Summary
  7.12.2 Abbott Laboratories Business Overview
  7.12.3 Abbott Laboratories Diabetic Retinopathy Treatment Major Product Offerings
  7.12.4 Abbott Laboratories Diabetic Retinopathy Treatment Revenue in Global Market (2017-2022)
  7.12.5 Abbott Laboratories Key News
7.13 Glycadia Pharmaceuticals
  7.13.1 Glycadia Pharmaceuticals Corporate Summary
  7.13.2 Glycadia Pharmaceuticals Business Overview
  7.13.3 Glycadia Pharmaceuticals Diabetic Retinopathy Treatment Major Product Offerings
  7.13.4 Glycadia Pharmaceuticals Diabetic Retinopathy Treatment Revenue in Global Market (2017-2022)
  7.13.5 Glycadia Pharmaceuticals Key News
7.14 Alcon Laboratories
  7.14.1 Alcon Laboratories Corporate Summary
  7.14.2 Alcon Laboratories Business Overview
  7.14.3 Alcon Laboratories Diabetic Retinopathy Treatment Major Product Offerings
  7.14.4 Alcon Laboratories Diabetic Retinopathy Treatment Revenue in Global Market (2017-2022)
  7.14.5 Alcon Laboratories Key News
7.15 Parexel International
  7.15.1 Parexel International Corporate Summary
  7.15.2 Parexel International Business Overview
  7.15.3 Parexel International Diabetic Retinopathy Treatment Major Product Offerings
  7.15.4 Parexel International Diabetic Retinopathy Treatment Revenue in Global Market (2017-2022)
  7.15.5 Parexel International Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Diabetic Retinopathy Treatment Market Opportunities & Trends in Global Market
Table 2. Diabetic Retinopathy Treatment Market Drivers in Global Market
Table 3. Diabetic Retinopathy Treatment Market Restraints in Global Market
Table 4. Key Players of Diabetic Retinopathy Treatment in Global Market
Table 5. Top Diabetic Retinopathy Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Diabetic Retinopathy Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Diabetic Retinopathy Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Diabetic Retinopathy Treatment Product Type
Table 9. List of Global Tier 1 Diabetic Retinopathy Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Diabetic Retinopathy Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Diabetic Retinopathy Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Diabetic Retinopathy Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Diabetic Retinopathy Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Diabetic Retinopathy Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Diabetic Retinopathy Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Diabetic Retinopathy Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Diabetic Retinopathy Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Diabetic Retinopathy Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Diabetic Retinopathy Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Diabetic Retinopathy Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Diabetic Retinopathy Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Diabetic Retinopathy Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Diabetic Retinopathy Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Diabetic Retinopathy Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Diabetic Retinopathy Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Diabetic Retinopathy Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Diabetic Retinopathy Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Diabetic Retinopathy Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Diabetic Retinopathy Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Regeneron Pharmaceuticals Corporate Summary
Table 31. Regeneron Pharmaceuticals Diabetic Retinopathy Treatment Product Offerings
Table 32. Regeneron Pharmaceuticals Diabetic Retinopathy Treatment Revenue (US$, Mn), (2017-2022)
Table 33. ThromboGenics Corporate Summary
Table 34. ThromboGenics Diabetic Retinopathy Treatment Product Offerings
Table 35. ThromboGenics Diabetic Retinopathy Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Genentech Corporate Summary
Table 37. Genentech Diabetic Retinopathy Treatment Product Offerings
Table 38. Genentech Diabetic Retinopathy Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Bayer Healthcare Corporate Summary
Table 40. Bayer Healthcare Diabetic Retinopathy Treatment Product Offerings
Table 41. Bayer Healthcare Diabetic Retinopathy Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Alimera Sciences Corporate Summary
Table 43. Alimera Sciences Diabetic Retinopathy Treatment Product Offerings
Table 44. Alimera Sciences Diabetic Retinopathy Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Actavis Corporate Summary
Table 46. Actavis Diabetic Retinopathy Treatment Product Offerings
Table 47. Actavis Diabetic Retinopathy Treatment Revenue (US$, Mn), (2017-2022)
Table 48. BCN Peptides Corporate Summary
Table 49. BCN Peptides Diabetic Retinopathy Treatment Product Offerings
Table 50. BCN Peptides Diabetic Retinopathy Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Novartis Corporate Summary
Table 52. Novartis Diabetic Retinopathy Treatment Product Offerings
Table 53. Novartis Diabetic Retinopathy Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Ampio Pharmaceuticals Corporate Summary
Table 55. Ampio Pharmaceuticals Diabetic Retinopathy Treatment Product Offerings
Table 56. Ampio Pharmaceuticals Diabetic Retinopathy Treatment Revenue (US$, Mn), (2017-2022)
Table 57. Kowa Group Corporate Summary
Table 58. Kowa Group Diabetic Retinopathy Treatment Product Offerings
Table 59. Kowa Group Diabetic Retinopathy Treatment Revenue (US$, Mn), (2017-2022)
Table 60. Sirnaomicsorporation Corporate Summary
Table 61. Sirnaomicsorporation Diabetic Retinopathy Treatment Product Offerings
Table 62. Sirnaomicsorporation Diabetic Retinopathy Treatment Revenue (US$, Mn), (2017-2022)
Table 63. Abbott Laboratories Corporate Summary
Table 64. Abbott Laboratories Diabetic Retinopathy Treatment Product Offerings
Table 65. Abbott Laboratories Diabetic Retinopathy Treatment Revenue (US$, Mn), (2017-2022)
Table 66. Glycadia Pharmaceuticals Corporate Summary
Table 67. Glycadia Pharmaceuticals Diabetic Retinopathy Treatment Product Offerings
Table 68. Glycadia Pharmaceuticals Diabetic Retinopathy Treatment Revenue (US$, Mn), (2017-2022)
Table 69. Alcon Laboratories Corporate Summary
Table 70. Alcon Laboratories Diabetic Retinopathy Treatment Product Offerings
Table 71. Alcon Laboratories Diabetic Retinopathy Treatment Revenue (US$, Mn), (2017-2022)
Table 72. Parexel International Corporate Summary
Table 73. Parexel International Diabetic Retinopathy Treatment Product Offerings
Table 74. Parexel International Diabetic Retinopathy Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Diabetic Retinopathy Treatment Segment by Type in 2021
Figure 2. Diabetic Retinopathy Treatment Segment by Application in 2021
Figure 3. Global Diabetic Retinopathy Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Diabetic Retinopathy Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Diabetic Retinopathy Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Diabetic Retinopathy Treatment Revenue in 2021
Figure 8. By Type - Global Diabetic Retinopathy Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Diabetic Retinopathy Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Diabetic Retinopathy Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Diabetic Retinopathy Treatment Revenue Market Share, 2017-2028
Figure 12. US Diabetic Retinopathy Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Diabetic Retinopathy Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Diabetic Retinopathy Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Diabetic Retinopathy Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Diabetic Retinopathy Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Diabetic Retinopathy Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Diabetic Retinopathy Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Diabetic Retinopathy Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Diabetic Retinopathy Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Diabetic Retinopathy Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Diabetic Retinopathy Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Diabetic Retinopathy Treatment Revenue Market Share, 2017-2028
Figure 24. China Diabetic Retinopathy Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Diabetic Retinopathy Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Diabetic Retinopathy Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Diabetic Retinopathy Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Diabetic Retinopathy Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Diabetic Retinopathy Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Diabetic Retinopathy Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Diabetic Retinopathy Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Diabetic Retinopathy Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Diabetic Retinopathy Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Diabetic Retinopathy Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Diabetic Retinopathy Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Diabetic Retinopathy Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Regeneron Pharmaceuticals Diabetic Retinopathy Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. ThromboGenics Diabetic Retinopathy Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Genentech Diabetic Retinopathy Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Bayer Healthcare Diabetic Retinopathy Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Alimera Sciences Diabetic Retinopathy Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Actavis Diabetic Retinopathy Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. BCN Peptides Diabetic Retinopathy Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Novartis Diabetic Retinopathy Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Ampio Pharmaceuticals Diabetic Retinopathy Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Kowa Group Diabetic Retinopathy Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Sirnaomicsorporation Diabetic Retinopathy Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Abbott Laboratories Diabetic Retinopathy Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Glycadia Pharmaceuticals Diabetic Retinopathy Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Alcon Laboratories Diabetic Retinopathy Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Parexel International Diabetic Retinopathy Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)